Cargando…
Investigating the Clinical Utility of the Anti-Mullerian Hormone Testing for the Prediction of Age at Menopause and Assessment of Functional Ovarian Reserve: A Practical Approach and Recent Updates
Low ovarian reserve is a serious condition, leading to sterility in up to 10% of women in their mid-thirties. According to current knowledge, serum anti-Müllerian hormone (AMH) levels for age are the best available marker for the screening the quantity of a woman’s functional ovarian reserve, better...
Autores principales: | Tehrani, Fahimeh Ramezani, Firouzi, Faezeh, Behboudi-Gandevani, Samira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947835/ https://www.ncbi.nlm.nih.gov/pubmed/35371603 http://dx.doi.org/10.14336/AD.2021.0825 |
Ejemplares similares
-
Does the Anti-Mullerian Hormone Decline Rate Improve the Prediction of Age at Menopause?
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2021) -
Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2021) -
Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function
por: Moolhuijsen, Loes M E, et al.
Publicado: (2020) -
The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis
por: Behboudi-Gandevani, Samira, et al.
Publicado: (2019) -
Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression
por: Bidhendi Yarandi, Razieh, et al.
Publicado: (2019)